Overview Atorvastatin in Myeloma Status: Unknown status Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma. Phase: Phase 1 Details Lead Sponsor: Bayside HealthTreatments: AtorvastatinAtorvastatin Calcium